INDICATIONS
Adult rheumatoid arthritis (RA)
ORENCIA® is suitable for alleviating the symptoms and signs of adult patients
with moderate to severe active rheumatoid arthritis, causing significant
clinical reactions, inhibiting the progression of structural damage and
improving physical function. In addition to tumor necrosis factor (TNF)
antagonists, Pharmaceutical
Consulting Company OERNCIA can also be used as a
monotherapy or in conjunction with disease-modifying anti-rheumatic drugs
(DMARD).
Juvenile idiopathic arthritis
ORENCIA is indicated for alleviating signs and symptoms of adolescent
idiopathic arthritis with moderately to severely active polyarticular joints
aged 2 years and older. ORENCIA can be used as a monotherapy or in combination
with methotrexate (MTX).
Adult Psoriatic Arthritis (PsA)
ORENCIA is designated for the treatment of adult patients with active psoriatic
arthritis (PsA).
Important usage restrictions
ORENCIA should not be used simultaneously with TNF antagonists. Named patient
supply It is not recommended to use ORENCIA together with other
biological rheumatoid arthritis (RA) treatments (such as anakinra).
No comments:
Post a Comment